Van Hulzen Asset Management, LLC Abb Vie Inc. Transaction History
Van Hulzen Asset Management, LLC
- $1.05 Billion
- Q1 2025
A detailed history of Van Hulzen Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 42,778 shares of ABBV stock, worth $8.18 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
42,778
Previous 169,374
74.74%
Holding current value
$8.18 Million
Previous $30.1 Million
70.22%
% of portfolio
0.85%
Previous 2.28%
Shares
32 transactions
Others Institutions Holding ABBV
# of Institutions
4,251Shares Held
1.27BCall Options Held
16.5MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA174MShares$33.3 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.3 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.87 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $338B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...